The effects of oral nanocurcumin in Multiple Sclerosis patients
Phase 2
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT2016042227520N1
- Lead Sponsor
- Drug Applied Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Willingness to cooperate;
Ranging in age from 28 to 51 years
MS diagnosis by neurologist
patients in relapse and remitting
EDSS<5/5
Exclusion Criteria
Used nutritional supplements and antioxidants and alpha lipoic acid within a month before the study
Pregnancy and lactation;
History of diabetes and other chronic diseases;
History of other autoimmune disease;
corticosteroid use during illness;
the occurrence of relapses during the study phase;
acceptance rate of less than 70% of supplements;
not wanting to continue cooperation.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method